Ultra Healthcare
Suketri, Panchkula, Haryana
GST No. 06ANYPJ1842N1ZC
TrustSEAL Verified
Call 08048971009 85% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 300 Bottle |
| Packaging Size | 200 ml |
| Pack Type | Box |
| Form | Syrup |
| Drug Composition | AMINO ACID MULTIVITAMIN SYRUP |
| Brand Name | VITOPIN A8 SYRUP |
| Manufacturer | ULTRA HEALTHCARE |
| Shelf Life | 18 Months |
| Usages | To support overall health and well-being by providing the body with the necessary nutrients |
| Prescription/Non Prescription | Prescription |
| Country of Origin | Made in India |
Vitopin-A8 Syrup is a health supplement designed to provide essential multivitamins, amino acids, and antioxidants, promoting overall health and well-being. The syrup is enriched with a balanced mix of nutrients such as Vitamin C, Niacinamide, D-Panthenol, and B-complex vitamins (B1, B2, B6, B12) which help boost immunity, enhance energy levels, and support the proper functioning of the body’s metabolic processes. Additionally, it contains dietary folate and amino acids like L-Lysine, L-Leucine, and L-Tryptophan, which aid in tissue repair, muscle growth, and protein synthesis. The antioxidant properties protect cells from oxidative stress caused by free radicals.
This supplement is ideal for individuals experiencing nutritional deficiencies, fatigue, or a need for improved immune support. Its sugar-free formulation and delicious mixed fruit flavor make it suitable for various age groups. However, it should be consumed as directed and not exceed the recommended dosage. Always consult a healthcare professional before use, especially for children or those with specific health conditions.
Additional Information:
Product Details:
| Minimum Order Quantity | 50000 Month |
| Promotional Material | Pens, Diaries, Notepads, Visual Aids, Calendars, Writing Pads, Visiting Cards, Bottle, Working Bag |
| Form of Medicine | Sachets, Capsule, Protein Powder, Drops, Tablet, Infusion, Ointments, Syrup, Injection |
| Certification | FSSAI, ISO, GLP, GMP, WHO |
| Product List Available | Yes |
| Range of Products | Gynaecology, Cardiac Diabetic, Antacids, Orthopedic, Antibiotics, Pediatrics, Neurological, Derma, Gastrointestinal, Ophthalmic |
| Medicine Type | Allopathic |
| Pharmaceutical Experience | Above 10 Years |
Additional Information:
Product Details:
| Minimum Order Quantity | 50000 Month |
| Product List Available | Yes |
| Pharmaceutical Experience | Above 10 Years |
| Service Mode | ONLINE AND OFFLINE |
| Service Duration | 30-40 DAYS |
| Form of Medicine | Capsule, Ointments, Syrup, Drops, Tablet, Protein Powder |
| Certification | GLP, ISO, WHO, GMP |
| Range of Products | Ophthalmic, Cardiac Diabetic, Antibiotics, Antacids, Gynaecology, Pediatrics |
Additional Information:
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.